BiOptic (ROCO:6850) Mohanram G-Score: 6 (As of Dec. 2025) — 20% Above Median


ROCO:6850 BiOptic Inc ROCO:6850
92 GF Score
Price NT$34.25
GF Value NT$44.90
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is BiOptic Mohanram G-Score?

BiOptic ROCO:6850 92 Mohanram G-Score is 6 as of Dec. 2025, which is 20% above its 10-year median of 5.00. GuruFocus rates ROCO:6850 with a GF Score™ of 92/100 and a GF Value™ of NT$44.90 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Mohanram G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. Companies have higher G-score tends to generate higher return. According to his study, the best growth stocks that have a G-Score greater than 6 tend to beat the market, while those with a G-Score lower than 1 tend to have negative absolute returns.

Thus, the zones of discrimination were as such:

Good or high score = 6, 7, 8
Bad or low score = 0, 1

BiOptic has an G-score of 6. It is a good or high score, which tends to beat the market.

The historical rank and industry rank for BiOptic's Mohanram G-Score or its related term are showing as below:

ROCO:6850' s Mohanram G-Score Range Over the Past 10 Years
Min: 5   Med: 5   Max: 6
Current: 6

During the past 8 years, the highest Piotroski G-score of BiOptic was 6. The lowest was 5. And the median was 5.

BiOptic  (ROCO:6850) Mohanram G-Score Explanation

Partha Mohanram is the John H. Watson Chair in Value Investing at Rotman and the Acting Vice-Dean of Research Strategy and Resources.

In 2000, he wrote a research paper called "Separating Winners from Losers Among Low Book-to-Market Stocks Using Financial Statement Analysis".

This paper tests whether a strategy based on financial statement analysis of low book-to-market (growth) stocks is successful in differentiating between winners and losers in terms of future stock performance. Based on the research, a strategy based on buying high G-score (6, 7 or 8) firms and shorting low G-score (0 or 1) firms consistently earns significant excess returns. Further, the results do not support a risk based explanation for the book-to-market effect as the strategy returns positive returns in all years, and firms that ex-ante appear less risky have better future returns.

To conclude, one can use a modified fundamental analysis strategy (G-score) to identify mispricing and earn substantial abnormal returns.


BiOptic Mohanram G-Score Related Terms


BiOptic Mohanram G-Score Historical Data

* Premium members only.

The historical data trend for BiOptic's Mohanram G-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BiOptic Mohanram G-Score Chart

BiOptic Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Mohanram G-Score
Get a 7-Day Free Trial N/A N/A 5.00 5.00 6.00

BiOptic Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Mohanram G-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 N/A 5.00 N/A 6.00

ROCO:6850 vs VRTX, REGN, ALNY: Mohanram G-Score Comparison

For the Biotechnology subindustry, BiOptic's Mohanram G-Score, along with its competitors' market caps and Mohanram G-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BiOptic Mohanram G-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BiOptic's Mohanram G-Score distribution charts can be found below:

* The bar in red indicates where BiOptic's Mohanram G-Score falls into.


ROCO:6850
92GF Score
BiOptic Inc ROCO:6850
Mohanram G-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BiOptic Mohanram G-Score Calculation

The calculation of the Mohanram G-score consists of eight criteria. Assign one point for each criterion met, then add up all the points to get the G-Score.

Profitability

Question 1. Return on Assets (ROA)

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. It measures how well a company uses its asset to generate earnings.

Score 1 if ROA > ROA Industry Median, 0 otherwise.

Question 2. Cash ROA

Cash ROA equals to Cash Flow from Operations divided by average Total Assets. It measures how well a company uses its asset to generate cash.

Score 1 if Cash ROA > Cash ROA Industry Median, 0 otherwise.

Question 3. CFO and Net Income

Score 1 if CFO > Net Income, 0 otherwise.

Earnings Predictability

Question 4. Earnings Variability

Earnings Variability is measured as the variance of a firm's ROA in the past five years.

Score 1 if Earnings Variability < Earnings Variability Industry Median, 0 otherwise.

Question 5. Sales Growth Variability

Sales Growth Variability is measured as the 5-year variance in sales growth.

Score 1 if Sales Growth Variability < Sales Growth Variability Industry Median, 0 otherwise.

Accounting Conservatism

Question 6. Research & Development Intensity

Research & Development Intensity is calcualted by Research & Development divided by the beginning Total Assets.

Score 1 if Research & Development Intensity > Research & Development Intensity Industry Median, 0 otherwise.

Question 7. CAPEX Intensity

CAPEX Intensity is calcualted by Capital Expenditure divided by the beginning Total Assets.

Score 1 if CAPEX Intensity > CAPEX Intensity Industry Median, 0 otherwise.

Question 8. Advertising Expenditure Intensity

Advertising Expenditure Intensity is calcualted by Advertising Expenditure divided by the beginning Total Assets. Note that Advertising Expenditure is not reported as a seperate line item for many companies, thus Selling, General, & Admin. Expense is used in this calculation.

Score 1 if Advertising Expenditure Intensity > Advertising Expenditure Intensity Industry Median, 0 otherwise.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note that all the Industry Median used for comparison in his original research, are substituted with Sector Median due to the limitation of data within certain countries.

Good or high score = 6, 7, 8
Bad or low score = 0, 1

BiOptic has an G-score of 6. It is a good or high score, which tends to beat the market.

Frequently Asked Questions Learn more about Mohanram G-Score →
What does a Mohanram G-Score of 6 mean?
BiOptic (ROCO:6850) has a Mohanram G-Score of 6 as of Dec. 2025. G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. View historical data on BiOptic and its competitors. This is 20% above median its historical median of 5.00. Over the past decade, BiOptic's Mohanram G-Score has ranged from 5.00 to 6.00.
Is BiOptic's Mohanram G-Score too high?
BiOptic's current Mohanram G-Score of 6 is 20% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 6.00. Overall, BiOptic has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BiOptic's Mohanram G-Score compare to VRTX and REGN?
BiOptic's Mohanram G-Score of 6 can be compared against companies in the Biotechnology industry. Historically, BiOptic's own Mohanram G-Score has ranged from 5.00 to 6.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Mohanram G-Score for a Biotechnology company?
A good Mohanram G-Score depends on the Biotechnology industry context. However, Mohanram G-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Mohanram G-Score mean?
A high Mohanram G-Score can signal that a stock is expensive relative to its fundamentals. G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. View historical data on BiOptic and its competitors. BiOptic's current Mohanram G-Score is 6, which is 20% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BiOptic stock overvalued right now?
Based on GuruFocus' analysis, BiOptic (ROCO:6850) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$44.90, compared to a current price of NT$34.25 — trading 23.7% below its estimated fair value. The current Mohanram G-Score is 6, which is 20% above median its 10-year median of 5.00. BiOptic's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Mohanram G-Score calculated?
Mohanram G-Score is calculated from a company's financial statements. For BiOptic (ROCO:6850), the current Mohanram G-Score is 6 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BiOptic (ROCO:6850) Overvalued in 2026?

Based on GuruFocus' analysis, BiOptic stock appears to be undervalued. The current stock price of NT$34.25 is trading 23.7% below its estimated GF Value™ of NT$44.90. GuruFocus considers BiOptic to be Modestly Undervalued.

Key valuation signals for ROCO:6850:

  • Mohanram G-Score: 6 (20% above median its 10-year median of 5.00)
  • GF Value™: NT$44.90 vs. price of NT$34.25 (23.7% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6850 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BiOptic Business Description

Address No. 108-3, Minquan Road, 4th Floor, Xindian District, New Taipei, TWN, 23141
BiOptic Inc is a biotechnology instrumentation company that develops scientific products for research and clinical applications. It serves professionals and laboratories dedicated to life science research, clinical diagnostics, pharmaceutical and food industries, animal husbandry, and agriculture, performing diagnostic molecular genetic analyses.
92GF Score

Get the complete analysis for ROCO:6850

Mohanram G-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.25
Price
NT$44.90
GF Value